Sangamo BioSciences Company Profile (NASDAQ:SGMO)

About Sangamo BioSciences

Sangamo BioSciences logoSangamo Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is focused on research, development and commercialization of engineered deoxyribonucleic acid (DNA)-binding proteins for therapeutic genome editing and gene regulation. It is engaged in developing zinc finger DNA-binding proteins (ZFP) therapeutics. Its ZFP Therapeutic, SB-728, a ZFP nuclease (ZFN)-modified autologous cell product for the treatment of Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS), is the therapeutic application of its ZFN genome editing technology and is evaluated in an ongoing Phase II study of ZFN-modified T-cells (SB-728-T-1101, Cohort 3) and a Phase I/II study of modified hematopoietic stem cells (SB-728mR-HSPC) in HIV-infected subjects. It has preclinical programs in hemophilia A and Lysergic acid diethylamide and research stage programs in monogenic diseases, including certain central nervous system disorders and cancer immunotherapy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SGMO
  • CUSIP: 80067710
Key Metrics:
  • Previous Close: $3.75
  • 50 Day Moving Average: $4.45
  • 200 Day Moving Average: $5.52
  • 52-Week Range: $3.50 - $9.91
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.99
  • P/E Growth: 0.00
  • Market Cap: $261.29M
  • Outstanding Shares: 70,618,000
  • Beta: 2.38
  • Net Margins: -261.81%
  • Return on Equity: -36.08%
  • Return on Assets: -32.05%
  • Current Ratio: 12.18%
  • Quick Ratio: 12.18%
Additional Links:
Companies Related to Sangamo BioSciences:

Analyst Ratings

Consensus Ratings for Sangamo BioSciences (NASDAQ:SGMO) (?)
Ratings Breakdown: 2 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $14.60 (289.33% upside)

Analysts' Ratings History for Sangamo BioSciences (NASDAQ:SGMO)
DateFirmActionRatingPrice TargetDetails
10/19/2016Piper Jaffray Cos.DowngradeOverweight -> Neutral$9.00 -> $5.00View Rating Details
8/10/2016Cowen and CompanyReiterated RatingBuyView Rating Details
8/5/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/4/2016Janney Montgomery ScottDowngradeBuy -> Neutral$15.00 -> $8.00View Rating Details
5/6/2016WedbushReiterated RatingOutperform$30.00View Rating Details
5/3/2016Wells Fargo & Co.Initiated CoverageBuyView Rating Details
2/10/2016JPMorgan Chase & Co.Reiterated RatingOverweight$16.00View Rating Details
5/19/2015BMO Capital MarketsReiterated RatingOutperform$19.00View Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Sangamo BioSciences (NASDAQ:SGMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2016Q316($0.25)$4.24 millionN/AView Earnings Details
8/3/2016Q216($0.24)($0.38)$5.38 million$3.70 millionViewN/AView Earnings Details
5/2/2016Q116($0.24)($0.23)$5.49 million$3.94 millionViewN/AView Earnings Details
2/9/2016Q415($0.21)($0.20)$9.86 million$9.10 millionViewN/AView Earnings Details
10/28/2015Q315($0.25)($0.13)$13.09 million$8.57 millionViewListenView Earnings Details
8/5/2015Q215($0.13)($0.17)$14.72 million$8.36 millionViewListenView Earnings Details
4/22/2015Q115($0.13)($0.08)$12.50 million$13.50 millionViewListenView Earnings Details
2/10/2015Q414($0.09)($0.06)$14.50 million$15.00 millionViewN/AView Earnings Details
10/22/2014Q314($0.04)($0.11)$8.27 million$12.40 millionViewListenView Earnings Details
7/23/2014Q214($0.14)($0.10)$7.84 million$10.38 millionViewListenView Earnings Details
5/6/2014Q114($0.13)($0.12)$6.59 million$8.10 millionViewListenView Earnings Details
2/11/2014Q413($0.10)($0.13)$8.90 million$6.90 millionViewListenView Earnings Details
10/23/2013Q313($0.11)($0.11)$5.52 million$5.70 millionViewN/AView Earnings Details
7/24/2013Q2 2013($0.12)($0.10)$4.77 million$6.90 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.17)($0.13)$3.79 million$4.60 millionViewN/AView Earnings Details
2/6/2013Q4 2012($0.12)($0.07)$5.95 million$8.93 millionViewN/AView Earnings Details
10/24/2012Q312($0.14)($0.11)$3.80 million$4.90 millionViewN/AView Earnings Details
7/25/2012($0.15)($0.11)ViewN/AView Earnings Details
5/2/2012($0.16)($0.14)ViewN/AView Earnings Details
10/25/2011($0.16)($0.18)ViewN/AView Earnings Details
7/27/2011($0.16)($0.20)ViewN/AView Earnings Details
4/26/2011($0.17)($0.21)ViewN/AView Earnings Details
2/2/2011($0.19)($0.18)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Sangamo BioSciences (NASDAQ:SGMO)
Current Year EPS Consensus Estimate: $-1.11 EPS
Next Year EPS Consensus Estimate: $-0.94 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.25)($0.25)($0.25)
Q3 20161($0.23)($0.23)($0.23)
Q4 20162($0.25)($0.22)($0.24)
Q1 20171($0.23)($0.23)($0.23)
Q2 20171($0.22)($0.22)($0.22)
Q3 20171($0.22)($0.22)($0.22)
Q4 20171($0.23)($0.23)($0.23)
(Data provided by Zacks Investment Research)


Dividend History for Sangamo BioSciences (NASDAQ:SGMO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Sangamo BioSciences (NASDAQ:SGMO)
Insider Ownership Percentage: 8.10%
Institutional Ownership Percentage: 65.10%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/1/2015Ra Capital Management, LlcMajor ShareholderSell27,770$12.82$356,011.40View SEC Filing  
7/30/2015Ra Capital Management, LlcMajor ShareholderSell109,590$12.42$1,361,107.80View SEC Filing  
7/29/2015Ra Capital Management, LlcMajor ShareholderSell1,407$12.41$17,460.87View SEC Filing  
7/28/2015Ra Capital Management, LlcMajor ShareholderSell60,081$12.11$727,580.91View SEC Filing  
7/25/2015Ra Capital Management, LlcMajor ShareholderSell47,429$12.31$583,850.99View SEC Filing  
7/24/2015Ra Capital Management, LlcMajor ShareholderSell124,050$12.28$1,523,334.00View SEC Filing  
7/17/2015Ra Capital Management, LlcMajor ShareholderBuy37,215$12.26$456,255.90View SEC Filing  
7/15/2015Edward O Lanphier IICEOSell25,000$10.43$260,750.00View SEC Filing  
7/13/2015Henry Ward WolffCFOSell12,000$10.00$120,000.00View SEC Filing  
7/1/2015Ra Capital Management, LlcMajor ShareholderSell82,700$16.01$1,324,027.00View SEC Filing  
6/16/2015Ra Capital Management, LlcMajor ShareholderSell250,500$16.55$4,145,775.00View SEC Filing  
6/9/2015Ra Capital Management, LlcMajor ShareholderSell83,500$15.50$1,294,250.00View SEC Filing  
6/6/2015Ra Capital Management, LlcMajor ShareholderSell135,101$14.29$1,930,593.29View SEC Filing  
6/5/2015Dale G AndoCMOSell15,000$12.29$184,350.00View SEC Filing  
6/5/2015Ra Capital Management, LlcMajor ShareholderSell115,102$14.13$1,626,391.26View SEC Filing  
6/4/2015Ra Capital Management, LlcMajor ShareholderSell70,640$13.10$925,384.00View SEC Filing  
6/3/2015Ra Capital Management, LlcMajor ShareholderSell76,833$12.86$988,072.38View SEC Filing  
6/3/2015William R RingoDirectorSell2,200$12.44$27,368.00View SEC Filing  
6/1/2015Philip D GregorySVPSell15,000$12.39$185,850.00View SEC Filing  
5/30/2015Ra Capital Management, LlcMajor ShareholderSell65,884$13.40$882,845.60View SEC Filing  
5/29/2015Ra Capital Management, LlcMajor ShareholderSell155,675$13.53$2,106,282.75View SEC Filing  
5/28/2015Ra Capital Management, LlcMajor ShareholderSell148,689$13.43$1,996,893.27View SEC Filing  
5/27/2015Ra Capital Management, LlcMajor ShareholderSell263,437$13.55$3,569,571.35View SEC Filing  
5/23/2015Ra Capital Management, LlcMajor ShareholderSell51,597$13.27$684,692.19View SEC Filing  
5/22/2015Ra Capital Management, LlcMajor ShareholderSell56,396$13.56$764,729.76View SEC Filing  
5/13/2015Ra Capital Management, LlcMajor ShareholderSell56,060$13.12$735,507.20View SEC Filing  
5/12/2015Ra Capital Management, LlcMajor ShareholderSell29,659$13.03$386,456.77View SEC Filing  
5/8/2015Ra Capital Management, LlcMajor ShareholderSell83,300$12.40$1,032,920.00View SEC Filing  
5/7/2015Ra Capital Management, LlcMajor ShareholderBuy35,736$12.09$432,048.24View SEC Filing  
5/5/2015Dale G AndoCMOSell15,000$12.29$184,350.00View SEC Filing  
5/4/2015William R RingoDirectorSell3,000$12.98$38,940.00View SEC Filing  
4/30/2015Ra Capital Management, LlcMajor ShareholderBuy124,500$13.45$1,674,525.00View SEC Filing  
4/28/2015Ra Capital Management, LlcMajor ShareholderBuy74,844$13.29$994,676.76View SEC Filing  
4/25/2015Ra Capital Management, LlcMajor ShareholderBuy166,000$13.63$2,262,580.00View SEC Filing  
4/22/2015Ra Capital Management, LlcMajor ShareholderSell352,750$14.86$5,241,865.00View SEC Filing  
4/17/2015Ra Capital Management, LlcMajor ShareholderBuy41,500$14.02$581,830.00View SEC Filing  
4/16/2015Ra Capital Management, LlcMajor ShareholderSell21,829$14.09$307,570.61View SEC Filing  
4/15/2015Edward O Lanphier IICEOSell25,000$15.33$383,250.00View SEC Filing  
4/15/2015Ra Capital Management, LlcMajor ShareholderBuy21,829$13.16$287,269.64View SEC Filing  
4/14/2015Ra Capital Management, LlcMajor ShareholderSell3,055$14.78$45,152.90View SEC Filing  
4/11/2015Ra Capital Management, LlcMajor ShareholderBuy116,992$14.48$1,694,044.16View SEC Filing  
4/10/2015Henry Ward WolffCFOSell12,000$15.31$183,720.00View SEC Filing  
4/10/2015Ra Capital Management, LlcMajor ShareholderBuy83,000$14.91$1,237,530.00View SEC Filing  
4/9/2015Ra Capital Management, LlcMajor ShareholderSell69,856$16.27$1,136,557.12View SEC Filing  
4/8/2015Ra Capital Management, LlcMajor ShareholderBuy121,876$15.49$1,887,859.24View SEC Filing  
4/7/2015Ra Capital Management, LlcMajor ShareholderBuy33,667$15.42$519,145.14View SEC Filing  
4/6/2015Dale G AndoCMOSell15,000$14.94$224,100.00View SEC Filing  
4/6/2015William R RingoDirectorSell2,200$14.95$32,890.00View SEC Filing  
4/4/2015Ra Capital Management, LlcMajor ShareholderBuy179,031$15.38$2,753,496.78View SEC Filing  
4/3/2015Ra Capital Management, LlcMajor ShareholderBuy195,126$16.61$3,241,042.86View SEC Filing  
4/1/2015Philip D GregorySVPSell15,000$15.15$227,250.00View SEC Filing  
4/1/2015Ra Capital Management, LlcMajor ShareholderSell250,000$18.01$4,502,500.00View SEC Filing  
3/28/2015Ra Capital Management, LlcMajor ShareholderBuy84,000$17.10$1,436,400.00View SEC Filing  
3/27/2015Ra Capital Management, LlcMajor ShareholderBuy256,187$17.65$4,521,700.55View SEC Filing  
3/26/2015Ra Capital Management, LlcMajor ShareholderBuy210,013$18.14$3,809,635.82View SEC Filing  
3/25/2015Ra Capital Management, LlcMajor ShareholderBuy84,000$19.42$1,631,280.00View SEC Filing  
3/21/2015Ra Capital Management, LlcMajor ShareholderBuy101,808$21.22$2,160,365.76View SEC Filing  
3/19/2015Henry Ward WolffCFOSell10,000$18.00$180,000.00View SEC Filing  
3/19/2015Ra Capital Management, LlcMajor ShareholderSell17,808$24.28$432,378.24View SEC Filing  
3/18/2015Ra Capital Management, LlcMajor ShareholderSell84,000$23.74$1,994,160.00View SEC Filing  
3/17/2015Ra Capital Management, LlcMajor ShareholderBuy52,161$23.02$1,200,746.22View SEC Filing  
3/16/2015Edward O Lanphier IICEOSell25,000$17.29$432,250.00View SEC Filing  
3/13/2015Ra Capital Management, LlcMajor ShareholderBuy71,319$22.76$1,623,220.44View SEC Filing  
3/12/2015Ra Capital Management, LlcMajor ShareholderSell123,480$23.40$2,889,432.00View SEC Filing  
3/10/2015Ra Capital Management, LlcMajor ShareholderBuy12,522$22.30$279,240.60View SEC Filing  
3/7/2015Ra Capital Management, LlcMajor ShareholderBuy258,377$22.25$5,748,888.25View SEC Filing  
3/6/2015Ra Capital Management, LlcMajor ShareholderSell61,483$24.10$1,481,740.30View SEC Filing  
3/3/2015Ra Capital Management, LlcMajor ShareholderSell84,000$18.21$1,529,640.00View SEC Filing  
3/3/2015William R RingoDirectorSell2,200$17.21$37,862.00View SEC Filing  
3/2/2015Philip D GregorySVPSell15,000$17.26$258,900.00View SEC Filing  
2/28/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$18.10$760,200.00View SEC Filing  
2/27/2015Ra Capital Management, LlcMajor ShareholderSell32,196$19.37$623,636.52View SEC Filing  
2/26/2015Ra Capital Management, LlcMajor ShareholderBuy74,194$19.57$1,451,976.58View SEC Filing  
2/20/2015Ra Capital Management, LlcMajor ShareholderSell35,319$18.40$649,869.60View SEC Filing  
2/19/2015Ra Capital Management, LlcMajor ShareholderSell6,720$18.51$124,387.20View SEC Filing  
2/18/2015Ra Capital Management, LlcMajor ShareholderSell11,172$18.11$202,324.92View SEC Filing  
2/14/2015Ra Capital Management, LlcMajor ShareholderSell15,380$18.61$286,221.80View SEC Filing  
2/13/2015Ra Capital Management, LlcMajor ShareholderSell15,409$18.46$284,450.14View SEC Filing  
2/12/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$18.04$757,680.00View SEC Filing  
2/12/2015Saira RamasastryDirectorSell10,000$15.00$150,000.00View SEC Filing  
2/11/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$19.65$825,300.00View SEC Filing  
2/7/2015Ra Capital Management, LlcMajor ShareholderSell34,688$18.52$642,421.76View SEC Filing  
2/6/2015Ra Capital Management, LlcMajor ShareholderSell7,312$18.42$134,687.04View SEC Filing  
2/5/2015Dale G AndoCMOSell15,000$12.93$193,950.00View SEC Filing  
2/5/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$18.23$765,660.00View SEC Filing  
2/3/2015William R RingoDirectorSell2,200$12.70$27,940.00View SEC Filing  
2/2/2015Philip D GregorySVPSell15,000$12.86$192,900.00View SEC Filing  
1/16/2015Edward O Lanphier IICEOSell25,000$14.22$355,500.00View SEC Filing  
1/12/2015Henry Ward WolffCFOSell12,000$15.87$190,440.00View SEC Filing  
1/5/2015Dale G AndoCMOSell15,000$15.19$227,850.00View SEC Filing  
1/5/2015William R RingoDirectorSell2,200$15.20$33,440.00View SEC Filing  
12/15/2014Edward O Lanphier IICEOSell25,000$15.40$385,000.00View SEC Filing  
12/15/2014John William LarsonDirectorSell10,000$16.28$162,800.00View SEC Filing  
12/9/2014John William LarsonDirectorSell10,000$12.00$120,000.00View SEC Filing  
12/1/2014Philip D GregorySVPSell15,000$11.68$175,200.00View SEC Filing  
11/17/2014Edward O Lanphier IICEOSell25,000$11.23$280,750.00View SEC Filing  
11/12/2014John William LarsonDirectorSell10,000$12.00$120,000.00View SEC Filing  
11/3/2014Philip D GregorySVPSell15,000$11.91$178,650.00View SEC Filing  
10/28/2014John William LarsonDirectorSell10,000$12.02$120,200.00View SEC Filing  
10/10/2014Henry Ward WolffCFOSell2,000$10.10$20,200.00View SEC Filing  
10/6/2014Dale G AndoCMOSell15,000$10.72$160,800.00View SEC Filing  
10/1/2014Philip D GregorySVPSell15,000$10.80$162,000.00View SEC Filing  
9/15/2014Edward O Lanphier IICEOSell25,000$12.14$303,500.00View SEC Filing  
9/10/2014Henry Ward WolffCFOSell2,000$12.31$24,620.00View SEC Filing  
9/5/2014Dale G AndoCMOSell15,000$12.20$183,000.00View SEC Filing  
9/4/2014John William LarsonDirectorSell10,000$12.81$128,100.00View SEC Filing  
8/15/2014Edward O Lanphier IICEOSell25,000$13.95$348,750.00View SEC Filing  
8/11/2014Henry Ward WolffCFOSell10,000$14.17$141,700.00View SEC Filing  
8/5/2014Dale G AndoCMOSell15,000$12.99$194,850.00View SEC Filing  
8/4/2014John William LarsonDirectorSell10,000$12.56$125,600.00View SEC Filing  
8/1/2014Philip D GregorySVPSell15,000$12.54$188,100.00View SEC Filing  
7/18/2014Edward O Lanphier IICEOSell25,000$12.16$304,000.00View SEC Filing  
7/10/2014Henry Ward WolffCFOSell15,000$13.26$198,900.00View SEC Filing  
7/1/2014Philip D GregorySVPSell15,000$15.66$234,900.00View SEC Filing  
6/23/2014Saira RamasastryDirectorSell5,550$15.53$86,191.50View SEC Filing  
6/16/2014Edward O Lanphier IICEOSell25,000$16.41$410,250.00View SEC Filing  
6/10/2014Henry Ward WolffCFOSell15,000$15.62$234,300.00View SEC Filing  
6/2/2014Philip D GregorySVPSell15,000$12.85$192,750.00View SEC Filing  
5/15/2014Edward Lanphier IICEOSell25,000$13.14$328,500.00View SEC Filing  
5/1/2014Philip GregorySVPSell15,000$13.68$205,200.00View SEC Filing  
4/28/2014Dale AndoCMOSell15,000$13.64$204,600.00View SEC Filing  
4/28/2014John William LarsonDirectorSell10,000$13.48$134,800.00View SEC Filing  
4/15/2014Edward Lanphier IICEOSell25,000$14.20$355,000.00View SEC Filing  
4/10/2014Henry Ward WolffCFOSell15,000$15.72$235,800.00View SEC Filing  
3/26/2014Dale AndoCMOSell15,000$18.65$279,750.00View SEC Filing  
3/21/2014Philip GregoryInsiderSell15,000$22.38$335,700.00View SEC Filing  
3/17/2014Edward Lanphier IICEOSell50,000$23.22$1,161,000.00View SEC Filing  
3/17/2014Saira RamasastryDirectorSell10,000$23.26$232,600.00View SEC Filing  
3/14/2014Steven MentoDirectorSell6,103$22.77$138,965.31View SEC Filing  
2/18/2014Edward Lanphier IICEOSell50,000$18.09$904,500.00View SEC Filing  
1/27/2014Dale AndoCMOSell15,000$18.58$278,700.00View SEC Filing  
1/10/2014Henry Ward WolffCFOSell10,000$18.69$186,900.00View SEC Filing  
1/2/2014Philip GregoryVPSell15,000$13.56$203,400.00View SEC Filing  
12/26/2013Dale AndoCMOSell15,000$14.37$215,550.00View SEC Filing  
11/15/2013Edward Lanphier IICEOSell25,000$10.11$252,750.00View SEC Filing  
11/5/2013Philip D GregoryVPSell15,000$9.60$144,000.00View SEC Filing  
10/28/2013Dale G AndoCMOSell15,000$10.39$155,850.00View SEC Filing  
10/21/2013Paul B ClevelandDirectorSell10,000$10.93$109,300.00View SEC Filing  
10/15/2013Edward O Lanphier IICEOSell25,000$11.32$283,000.00View SEC Filing  
10/10/2013Henry Ward WolffCFOSell10,000$11.28$112,800.00View SEC Filing  
10/1/2013Philip D GregoryVPSell15,000$10.54$158,100.00View SEC Filing  
9/16/2013Edward Lanphier IICEOSell25,000$11.29$282,250.00View SEC Filing  
9/10/2013Henry Ward WolffCFOSell10,000$10.86$108,600.00View SEC Filing  
9/3/2013Paul ClevelandDirectorSell7,278$10.30$74,963.40View SEC Filing  
9/3/2013Philip GregoryVPSell15,000$10.33$154,950.00View SEC Filing  
8/26/2013Dale AndoCMOSell15,000$10.04$150,600.00View SEC Filing  
8/15/2013Edward Lanphier IICEOSell25,000$10.12$253,000.00View SEC Filing  
8/13/2013Henry Ward WolffCFOSell10,000$10.00$100,000.00View SEC Filing  
8/1/2013Philip GregoryVPSell15,000$9.89$148,350.00View SEC Filing  
7/29/2013Philip D GregoryVPSell15,000$10.04$150,600.00View SEC Filing  
7/26/2013Dale G AndoCMOSell15,000$10.09$151,350.00View SEC Filing  
7/17/2013Edward O Lanphier IICEOSell25,000$10.00$250,000.00View SEC Filing  
7/17/2013Henry Ward WolffCFOSell10,000$10.00$100,000.00View SEC Filing  
7/15/2013Paul B ClevelandDirectorSell8,000$9.59$76,720.00View SEC Filing  
6/3/2013Philip D GregoryVPSell3,000$7.88$23,640.00View SEC Filing  
5/28/2013Dale G AndoCMOSell15,000$8.32$124,800.00View SEC Filing  
4/10/2013Henry Ward WolffCFOSell10,000$10.00$100,000.00View SEC Filing  
12/26/2012Dale G AndoCMOSell17,000$5.92$100,640.00View SEC Filing  
12/3/2012John William LarsonDirectorSell15,000$5.64$84,600.00View SEC Filing  
9/5/2012Dale G AndoCMOSell15,000$5.60$84,000.00View SEC Filing  
9/4/2012John William LarsonDirectorSell15,000$5.30$79,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Sangamo BioSciences (NASDAQ:SGMO)
News IconTwo Biotech Stocks Are Just So Hot Right Now: Sangamo Biosciences (SGMO), Celldex Therapeutics (CLDX) - The Independent Republic (NASDAQ:SGMO) - October 21 at 10:52 AM
News IconTwo Biotech Stocks Are Just So Hot Right Now: Sangamo Biosciences Inc. (SGMO), Celldex Therapeutics, Inc. (CLDX) - The Independent Republic (NASDAQ:SGMO) - October 21 at 10:52 AM
News IconSangamo BioSciences Inc. (SGMO) Lowered to Neutral at Piper Jaffray Cos (NASDAQ:SGMO) - October 20 at 7:34 PM logoMid-Afternoon Market Update: Imperva Tumbles Amid Sale Concerns; Banc of California Shares Surge (NASDAQ:SGMO) - October 20 at 6:08 AM logoSangamo Biosciences (SGMO) R&D EVP Resigns (NASDAQ:SGMO) - October 19 at 7:58 PM logoSangamo BioSciences Announces Third Quarter 2016 Conference Call and Webcast (NASDAQ:SGMO) - October 19 at 7:58 PM logoSangamo BioSciences : Announces Participation In Upcoming Scientific Conferences (NASDAQ:SGMO) - October 18 at 7:08 PM logoSANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:SGMO) - October 18 at 7:08 PM logoSangamo BioSciences Announces Participation In Upcoming ... - PR Newswire (press release) (NASDAQ:SGMO) - October 17 at 7:06 PM logoSangamo BioSciences Announces Participation In Upcoming Scientific Conferences (NASDAQ:SGMO) - October 17 at 7:06 PM
News IconEarnings Analysis & Update for Sangamo BioSciences, Inc. (NASDAQ:SGMO)? - CSZ News (NASDAQ:SGMO) - October 17 at 12:34 PM
News Icon2 Stocks Analyst-Opinion Need Close Attention Sangamo Biosciences, Inc. (NASDAQ:SGMO), The Western Union ... - The Voice Registrar (NASDAQ:SGMO) - October 17 at 12:34 PM
News IconTop Earnings to Watch for: Sangamo Biosciences Inc. (NASDAQ:SGMO) - The Voice Registrar (NASDAQ:SGMO) - October 14 at 7:03 PM logoBiotech Stocks on Investors' Radar -- Arena Pharma, Progenics Pharma, Sangamo Biosciences, and Alnylam Pharma - PR Newswire (press release) (NASDAQ:SGMO) - October 13 at 11:03 AM
News IconHistory of Sangamo Biosciences Inc. (NASDAQ:SGMO) stock price after earnings - The Independent Republic (NASDAQ:SGMO) - October 13 at 11:03 AM logoETF’s with exposure to Sangamo BioSciences, Inc. : October 11, 2016 (NASDAQ:SGMO) - October 11 at 2:29 PM
News IconWhat is the Sell-side Saying About Sangamo BioSciences, Inc. (NASDAQ:SGMO)? - CSZ News (NASDAQ:SGMO) - October 10 at 12:02 PM
News IconBiotech news that matter for investors: Curis, Inc. (NASDAQ:CRIS), Sangamo Biosciences Inc. (NASDAQ:SGMO) - The Voice Registrar (NASDAQ:SGMO) - October 5 at 12:34 PM
News IconBiotech news that matter for investors: Sangamo Biosciences Inc. (NASDAQ:SGMO), BioDelivery Sciences ... - The Voice Registrar (NASDAQ:SGMO) - October 1 at 8:00 AM
News IconTrading the Biotech News: Ligand Pharmaceuticals (NASDAQ:LGND), Sangamo Biosciences (NASDAQ:SGMO) - The Voice Registrar (NASDAQ:SGMO) - September 29 at 12:41 PM logoSangamo BioSciences, Inc. – Value Analysis (NASDAQ:SGMO) : September 27, 2016 (NASDAQ:SGMO) - September 27 at 11:54 AM
News IconBiotech Stocks To Put On Your Watch List: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Sangamo Biosciences Inc ... - The Voice Registrar (NASDAQ:SGMO) - September 26 at 7:19 PM logoSangamo BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : SGMO-US : September 26, 2016 (NASDAQ:SGMO) - September 26 at 7:19 PM
News IconWhat are Research Firms Saying About Sangamo BioSciences, Inc. (NASDAQ:SGMO)? - Frisco Fastball (NASDAQ:SGMO) - September 25 at 1:40 PM
News Icon2 Biotech Stocks News And Price Trends: Sangamo Biosciences Inc. (NASDAQ:SGMO), Vertex Pharmaceuticals ... - The Voice Registrar (NASDAQ:SGMO) - September 23 at 11:56 AM
News IconSell-side is Weighing in on Sangamo BioSciences, Inc. (NASDAQ:SGMO) Earnings & Targets - Frisco Fastball (NASDAQ:SGMO) - September 22 at 6:55 PM
News IconCommit To Buy Sangamo BioSciences At $3, Earn 23.3% Using Options (NASDAQ:SGMO) - September 21 at 6:51 PM logoETF’s with exposure to Sangamo BioSciences, Inc. : September 21, 2016 (NASDAQ:SGMO) - September 21 at 11:21 AM
News IconWhat are Brokerage Firms Saying About Sangamo BioSciences, Inc. (NASDAQ:SGMO)? - Frisco Fastball (NASDAQ:SGMO) - September 20 at 12:36 PM
News IconTime To Put On The Watch List? - Sangamo Biosciences Inc. (NASDAQ:SGMO), Nektar Therapeutics (NASDAQ:NKTR) - The Voice Registrar (NASDAQ:SGMO) - September 19 at 11:50 AM
News IconPlacing Sangamo BioSciences, Inc. (NASDAQ:SGMO) Shares Under the Microscope - Post News (NASDAQ:SGMO) - September 9 at 6:53 PM
News IconAnalysts Valuations For Two Stocks: Sangamo Biosciences, Inc ... - The Voice Registrar (NASDAQ:SGMO) - September 9 at 6:53 PM
News IconThe Statistics Don't Lie: Sangamo Biosciences Inc. (NASDAQ:SGMO ... - The Voice Registrar (NASDAQ:SGMO) - September 8 at 6:57 PM
News IconAnalysts Valuations For Two Stocks: Patterson-UTI Energy, Inc. (NASDAQ:PTEN), Sangamo Biosciences, Inc ... - The Voice Registrar (NASDAQ:SGMO) - September 7 at 10:58 AM
News IconHot Biotech Stocks To Watch Right Now: Sangamo Biosciences Inc. (SGMO), Amicus Therapeutics, Inc. (FOLD) - The Independent Republic (NASDAQ:SGMO) - September 7 at 10:58 AM
News IconIntraday Active Biotech Stocks News: ImmunoGen, Inc. (NASDAQ:IMGN), Sangamo Biosciences Inc. (NASDAQ:SGMO) - The Voice Registrar (NASDAQ:SGMO) - September 7 at 10:58 AM logoCompany Update (NASDAQ:SGMO): Sangamo Biosciences, Inc. Receives Orphan Drug Designation From The FDA ... - Smarter Analyst (NASDAQ:SGMO) - September 7 at 10:58 AM logoSangamo Biosciences (SGMO) Granted FDA Orphan Drug ... - (NASDAQ:SGMO) - September 6 at 12:00 PM logo7:03 am Sangamo BioSci confirms orphan designation for its Adeno-associated virus serotype 2/6 vectors encoding zinc finger nucleases and human factor 9 gene for the treatment of hemophilia B (NASDAQ:SGMO) - September 6 at 12:00 PM logoSangamo BioSciences Receives Orphan Drug Designation From The FDA For SB-FIX, The First Application Of Therapeutic In Vivo Genome Editing (NASDAQ:SGMO) - September 6 at 12:00 PM logoSangamo BioSciences : Announces Participation At Upcoming Investor Conferences (NASDAQ:SGMO) - September 1 at 10:28 AM logoSangamo BioSciences Announces Participation At Upcoming Investor Conferences (NASDAQ:SGMO) - September 1 at 10:28 AM logoWill Sangamo BioSciences, Inc. (NASDAQ:SGMO) Hit $30 Price Target? - Investor Newswire (NASDAQ:SGMO) - August 21 at 11:18 AM logoETF’s with exposure to Sangamo BioSciences, Inc. : August 19, 2016 (NASDAQ:SGMO) - August 19 at 7:14 PM logoSANGAMO BIOSCIENCES INC Financials (NASDAQ:SGMO) - August 13 at 6:58 PM logoSangamo BioSciences, Inc. :SGMO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:SGMO) - August 11 at 7:53 PM logoNew 52 Week Lows After the Bell – (NASDAQ: MYGN), (NASDAQ: SPWR), (NYSE: TDW), (NASDAQ: MCHX), (NYSE: PRGO), (NASDAQ: CSIQ) (NASDAQ:SGMO) - August 11 at 10:40 AM logoCowen Optimistic on Sangamo Biosciences, Inc. (SGMO) Following 2Q:16 Results, Despite Recent Clinical Delays - Smarter Analyst (NASDAQ:SGMO) - August 10 at 10:32 AM logoSangamo BioSciences Announces Presentation At The 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:SGMO) - August 9 at 7:41 PM logoETF’s with exposure to Sangamo BioSciences, Inc. : August 8, 2016 (NASDAQ:SGMO) - August 8 at 7:37 PM


Sangamo BioSciences (NASDAQ:SGMO) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff